In extremely preterm infants receiving surfactant, early intratracheal budesonide had little to no effect on survival free of bronchopulmonary dysplasia (BPD), a randomized clinical trial found.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback